Avalon GloboCare Corp. entered into a securities purchase agreement on June 30, 2026 to sell $400,000 of Series F Convertible Preferred Stock and common stock to an accredited investor. The preferred shares have a stated value of $1,000 each, are convertible into common stock at $0.50 per share, and require mandatory redemption of 25% of the outstanding shares on four dates starting October 2026 at 125% of the stated value. The transaction also includes 200,000 commitment shares of common stock and closed on July 2, 2026 as an unregistered sale.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding AVALON GLOBOCARE CORP (ALBT)?

Major stakeholders currently include Equitable Holdings, Inc. ($72.0K), Geode Capital Management, LLC ($32.9K), Vanguard Capital Management LLC ($30.4K). Based on the latest 13F filings, there are a total of 20 tracked investment funds and institutions maintaining positions in ALBT.

What is the overall institutional sentiment toward ALBT recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $157.1K, driven by 12 managers accumulating shares while 4 reduced their exposure.

Which institutions have been selling or reducing their ALBT positions?

In the latest period, 2 funds trimmed their holdings, and 2 managers completely exited their positions. The aggregate reported sell value was $51.6K.

Are there any notable investors adding ALBT to their portfolios?

Yes, buying activity remains notable. 7 institutions opened new positions in {ticker}, and 5 existing holders added to their shares. The total reported buy value for the quarter amounted to $227.7K.